GENITOURINARY CANCER
Clinical trials for GENITOURINARY CANCER explained in plain language.
Never miss a new study
Get alerted when new GENITOURINARY CANCER trials appear
Sign up with your email to follow new studies for GENITOURINARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New scan could tell doctors in weeks, not months, if cancer drug is failing
Diagnosis CompletedThis study tested a new type of PET scan to see if it could detect whether targeted therapy drugs were working for advanced kidney cancer much sooner than current methods. The goal was to see if changes in tumor blood flow, measured by a special scan just 1-2 weeks after starting…
Matched conditions: GENITOURINARY CANCER
Phase: NA • Sponsor: University of California, Davis • Aim: Diagnosis
Last updated Mar 23, 2026 15:29 UTC
-
Scientists track inflammation to predict cancer drug side effects
Knowledge-focused CompletedThis study aims to understand when inflammation peaks in the body after starting a common type of cancer immunotherapy. Researchers measured markers in the blood of 98 adults with various cancers to see if these markers could predict side effects or interactions with other medica…
Matched conditions: GENITOURINARY CANCER
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC